[Isolated laringeal leishmaniasis and bone marrow culture (reply)].
Benítez
M Dolores
MD
Miranda
Consuelo
C
Navarro
José M
JM
Morillas
Fernando
F
Martín
Josefa
J
de La Rosa
Manuel
M
D000328:Adult; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001706:Biopsy; D001853:Bone Marrow / Q000469:parasitology / Q000473:pathology*; D001854:Bone Marrow Cells / Q000469:parasitology; D002478:Cells, Cultured / Q000469:parasitology; D006801:Humans; D007818:Laryngeal Diseases / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D007830:Larynx / Q000469:parasitology / Q000473:pathology; D018314:Leishmania infantum / Q000302:isolation & purification*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate